Brian Armstrong's Newlimit Raises $435M, Valuation Hits $3.1B

Brian Armstrong’s anti-aging company Newlimit secured $435 million in Series C funding, tripling its valuation to $3.1 billion. Human trials are planned for next year.

What's Hot

Perplexity Fine-Tunes Chinese AI to Match Claude Opus at Lower Cost

Crypto Clarity Act’s New Version May Drop Next Week

Relay Protocol Warns of Robinhood Chain Honeypot Scams

Warsh Recruits Finance Experts for US Monetary Policy Review

Uniswap Fee Switch Debate Highlights DeFi Revenue Challenges

SWIFT Taps Ripple-Linked Banks for Blockchain Payments, XRP Rises

Tokenized Stocks Surge 279% to Record $3.4B

Kraken Adds Fiat Margin Pairs for Active Traders

Over 15 Banks Tokenizing Finance, Potentially Impacting Bitcoin

New Hampshire Rejects $100M Bitcoin Bond Proposal

Brian Armstrong’s Newlimit Raises $435M, Valuation Hits $3.1B

Perplexity Fine-Tunes Chinese AI to Match Claude Opus at Lower Cost

Crypto Clarity Act’s New Version May Drop Next Week

Relay Protocol Warns of Robinhood Chain Honeypot Scams

Warsh Recruits Finance Experts for US Monetary Policy Review

Perplexity Fine-Tunes Chinese AI to Match Claude Opus at Lower Cost

Crypto Clarity Act’s New Version May Drop Next Week

Relay Protocol Warns of Robinhood Chain Honeypot Scams

What's Hot

Brian Armstrong’s Newlimit Raises $435M, Valuation Hits $3.1B

Related Posts